BRIEF published on 04/30/2024 at 18:05, 2 years 6 months ago Breakthrough in Treatment for Macular Degeneration Blindness by Mesogen Inc. Biotechnology Healthcare Innovation Mesogen Inc Macular Degeneration Stem Cell Treatment
PRESS RELEASE published on 04/30/2024 at 18:00, 2 years 6 months ago Texas Company's Mission to Cure Macular Degeneration Blindness Mesogen Inc. from The Woodlands, Texas, developed a transplantable RPE patch for Macular Degeneration Blindness using autologous stem cells with no teratoma tumor risk Stem Cells Treatment Mesogen Inc. Macular Degeneration Blindness RPE Patch
Published on 11/11/2026 at 23:30, 1 minute ago Faraday Copper Reports Third Quarter 2026 Financial Results and Announces Changes to the Board of Directors
Published on 11/11/2026 at 23:05, 26 minutes ago Vox Royalty Reports Q3 2026 Results and Declares Quarterly Dividend
Published on 11/11/2026 at 23:00, 31 minutes ago CCL Industries Announces Appointment of New Director
Published on 11/11/2026 at 22:30, 1 hour 1 minute ago 55 North Gold Qualifies for Trading on the OTCQB Venture Market and Launches New Corporate Website
Published on 11/11/2026 at 19:31, 4 hours ago Lion Copper Corp. Completes S-K 1300 Technical Report Summary for Bear Copper Deposit
Published on 11/11/2026 at 19:29, 4 hours 2 minutes ago EQS-Adhoc: Allianz SE: Allianz delivers record nine-month result of 14.1 billion euros and raises 2026 outlook
Published on 11/11/2026 at 18:41, 4 hours 49 minutes ago AUSTRIACARD HOLDINGS AG: 9M 2026 Financial Results
Published on 11/10/2026 at 17:31, 1 day 5 hours ago CNP Assurances SA announces the success of the issuance of a €500 million Tier 2 subordinated bond.
Published on 11/10/2026 at 14:00, 1 day 9 hours ago Guillemot Corporation S.A. | Weekly report share buyback from November 2 to November 6, 2026
Published on 11/10/2026 at 11:02, 1 day 12 hours ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 1 day 16 hours ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/09/2026 at 18:30, 2 days 5 hours ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
